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Abstract
In this work, an electrochemical paper-based aptasensor was fabricated for label-free and ultrasensitive detection of
epidermal growth factor receptor (EGFR) by employing anti-EGFR aptamers as the bio-recognition element. The device
used the concept of paper-folding, or origami, to serve as a valve between sample introduction and detection, so
reducing sampling volumes and improving operation convenience. Amino-functionalized graphene (NH2-GO)/
thionine (THI)/gold particle (AuNP) nanocomposites were used to modify the working electrode not only to generate
the electrochemical signals, but also to provide an environment conducive to aptamer immobilization.
Electrochemical characterization revealed that the formation of an insulating aptamer–antigen immunocomplex
would hinder electron transfer from the sample medium to the working electrode, thus resulting in a lower signal. The
experimental results showed that the proposed aptasensor exhibited a linear range from 0.05 to 200 ngmL−1 (R2=
0.989) and a detection limit of 5 pgmL−1 for EGFR. The analytical reliability of the proposed paper-based aptasensor
was further investigated by analyzing serum samples, showing good agreement with the gold-standard enzyme-
linked immunosorbent assay.
Introduction
Epidermal growth factor receptor (EGFR), with tyrosine
kinase activity, is a transmembrane glycoprotein1,2. Once
bound to its specific ligands, it can activate specific genes,
promoting cell division and proliferation3. The normal
EGFR concentration in humans is in the range of
1–25 ngml−1 (ref. 4); however, overexpression of EGFR
occurs in a variety of carcinomas, including gastric, breast,
ovarian, and colorectal cancers5. For example, the con-
centration of EGFR in the lymph node metastasis of lung
cancer patients can be as high as 850 ngml−1 (ref. 6).
Hence, there has been increasing interest in the deter-
mination of EGFR levels as a basis for early-stage cancer
identification7.
In clinical laboratories, various technologies, including
enzyme-linked immunosorbent assay (ELISA)8, western
blotting9, and immunohistochemistry (IHC)10, have been
developed for the detection of EGFR. For example, Atkins
et al. used an IHC-based screening method for the
detection of EGFR with the EGFR pharmDX kit11. How-
ever, these techniques face challenges ranging from their
detection ranges, sensitivities, assay complexity to the cost
of equipment12,13. To overcome these limitations, elec-
trochemical detection methods have been developed for
the quantitative detection of EGFR. For example, Ilkhani
et al. reported a new electrochemical aptamer/antibody-
based sandwich immunosensor with a linear sensing
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range of 1–40 ngmL−1 and a detection limit of 50 pgmL−1
(ref. 5). Although these methods are relatively simple, easy
to perform, and can be used in point-of-care testing
(POCT) formats, they have limited effectiveness. Thus,
efforts are underway to develop label-free quantitative
assays with low system complexity for monitoring the
concentrations of EGFR in real time. Label-free electro-
chemical assays, which can directly convert a biological
recognition event, such as ligand binding of a biomarker,
into a measurable electrical signal, have the potential to
address many of the abovementioned issues14,15.
Microfluidic devices have been widely used as analysis
platforms, as a consequence of the need for convenient
POCT formats16,17. Currently, most microfluidic analy-
tical devices are fabricated using glass, silicon, or poly-
meric channels, the latter involving soft-lithography of
polydimethylsiloxane18 or polymethyl methacrylate19, for
example. However, these devices usually require complex
fabrication processes and external pumping forces for
liquid transportation, which largely restrict their applica-
tions. Thus, microfluidic paper-based devices (μPADs)20,
which are fabricated on paper, have gained considerable
attention as alternative platforms for detection. They are
attractive because of advantages, such as their relatively
low cost. The paper matrix enables flow through capillary
forces, which facilitates the transportation of samples and
reagents without the need for external equipment21.
Moreover, many low-cost methods have been demon-
strated for μPADs fabrication, including photo-
lithography22, ink jet printing23, plasma treatment24, laser
treatment25, screen printing26, and wax printing27.
Among all these methods, wax printing is a rapid and easy
method for producing large-scale µPADs with no
requirement for a clean room facility28. The cost for
µPADs fabrication based on wax printing is also modest.
Due to these advantages, wax-printed paper has become
an attractive substrate in the field of detection29.
Currently, different detection mechanisms have been
used in μPADs for point-of-care applications30. In 2007,
the Whitesides research group at Harvard University first
reported a novel μPAD to analyze glucose and proteins in
urine by colorimetry20. The qualitative results of the assay
could be read directly by the naked eye or semiquantita-
tively with digital equipment. In an effort to conduct
quantitative analysis for diagnostic tests based on μPADs,
electrochemical detection methods have been successfully
introduced onto the device31—providing an attractive
alternative detection scheme for paper-based micro-
fluidics due to their high sensitivity and high selectivity32.
An additional advantage of the electrochemical method is
the simplicity of the instrumentation, resulting in low
electrical power requirements for handheld or in-field
use33.
Aptamers are DNA or RNA sequences that are selected
in vitro by the mature technology systematic evolution of
ligands by exponential enrichment34,35. Due to their
ability to bind with specific molecular targets, they have
been widely regarded as promising recognition elements
for biosensor applications, particularly for the detection of
protein analytes36. In addition to exhibiting high affinity,
they also possess several key advantageous properties,
including ease and cost of production, as well as their
potential for chemical modification to yield improved and
tailored properties, providing improved stability and shelf
life at ambient temperature, compared with antibodies;37–39
lack of aggregation; as well as good pH and temperature
tolerance—all making the proposed approach potentially
suitable for future clinical applications40. Combining the
attractive properties of aptamers with the distinct
advantages of electrochemical detection methods has
received increasing attention. Electrochemistry offers
innovative routes for interfacing aptamer interactions
with the signal-generating element and for obtaining
protein diagnostics in a simple, fast, and inexpensive
manner41. To enhance the sensitivity and selectivity of
electrochemical aptasensors, a variety of nanomaterials
have been employed to modify electrodes42. For example,
graphene has distinct electrical properties43 and
graphene-modified electrodes not only facilitate the
transfer rate of electrons, but also provide a large surface
for biomolecule immobilization, resulting in improved
sensitivity44.
Here, we demonstrated an origami-paper-based device
employing an electrochemical detection method for
highly sensitive and POCT of EGFR. The hydrophobic
and hydrophilic areas on the device, to define fluid
channels were created by the printing of wax, while
electrochemical electrodes were made by screen printing.
The device enabled sample processing and detection by
simply folding the paper to enable flow or valving. Amino-
functionalized graphene (NH2-GO)/thionine (THI)/gold
particle (AuNP) nanocomposites were synthesized to
modify the working electrode (WE) not only to generate a
response, but also to help immobilize aptamers through
Au-S bonds. The anti-EGFR aptamers were pre-
synthesized and modified with thiol groups. A simple
electrochemical detection method that avoided labeling
either antigen or aptamer was adopted. The principle of
the biosensor was based upon the fact that the electron
transfer rate would be inhibited with the formation of
aptamer–antigen bioconjugates, resulting in a decrease in
the measured current. The origami-paper-based device,
with low cost and low sample consumption, offers an
alternative, promising platform for EGFR detection for
POCT sensing in early diagnosis and efficacy evaluation of
cancer.
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Materials and methods
Reagents and apparatus
The anti-EGFR aptamer, modified with thiol groups on
its 5′-end, was purchased from Sangon Biotechnology Co.
Ltd. (Shanghai, China). The aptamer was purified by high-
performance liquid chromatography, and its sequence was
5′-TAC CAG TGC GAT GCT CAG TGC CGT TTC
TTC TCT TTC GCT TTT TTT GCT TTT GAG CAT
GCT GAC GCA TTC GGT TGA C-3′ (Mw
23474.2 gmol−1). Whatman No. 1 chromatography paper
was purchased from GE Healthcare worldwide. The inks,
including conductive carbon ink (ED581ss), were pur-
chased from Acheson, and Ag|AgCl ink (CNC-01) was
purchased from Yingman Nanotechnology Company
(China). EGFR antigens, EGFR ELISA kits, and tris-
ethylenediaminetetraacetic (TE) buffer solution (pH=
8.0) were also purchased from Sangon Biotechnology Co.
Ltd. Thionin acetate was obtained from Alfa Asear, and
NH2-GO was purchased from Nanjing Xianfeng Nano-
materials Company (China). All reagents were of analy-
tical grade and used without further purification.
Electrochemical characterization and analytical mea-
surements, including cyclic voltammetry (CV) and dif-
ferential pulse voltammetry (DPV), were carried out on an
Autolab PGSTAT302N electrochemical workstation
(Autolab, Herisau, Switzerland). A Xerox ColorQube
8570 digital wax printer was used to fabricate hydro-
phobic areas on paper. Ultrapure water was purified by a
Michem water apparatus (Michem, China, resistivity >
18MΩ). The morphology of the synthesized nano-
composites was characterized by a Hitachi H7650 trans-
mission electron microscope (Hitachi, Japan).
Design and fabrication of origami-paper-based device
A simple illustration of the origami-paper-based
device, which was designed using Adobe Illustrator
CS5, is shown in Fig. 1. The devices were directly fab-
ricated by a wax printer without needing any cleanroom
access. Wax was printed onto the surface of chromato-
graphy paper to selectively create hydrophobic area
(colored) and hydrophilic channels (white). The wax-
patterned filter paper was then heated at 120 °C for
5 min in an oven, letting the wax melt and penetrate into
the paper in the z-direction, creating a hydrophobic
barrier through the whole thickness of the paper (z)
rather than just on the surface. Subsequently, three
electrodes were screen printed onto the device. The WE
was fabricated on the front of the device using con-
ductive carbon ink. The carbon ink counter electrode
and Ag|AgCl ink reference electrode (RE) were screen
printed on the back side.
Preparation of origami-paper-based EGFR aptasensor
A schematic illustration of the origami-paper-based
EGFR aptasensor preparation process is shown in Fig. 2.
Briefly, NH2-GO/THI/AuNP nanocomposites were first
synthesized and then coated onto the surface of the WE to
help immobilize anti-EGFR aptamers. The specific mod-
ification process can be described as follows.
For the preparation of NH2-GO/THI/AuNP nano-
composites, 2.0 mg of NH2-GO was first dispersed into
2.0 mL of ultrapure water by ultrasonication for half an
hour, followed by the addition of 2.0 mL of stable THI
solution (2.0 mgmL−1). The above mixture was stirred
vigorously for 24 h at room temperature to obtain NH2-
GO/THI nanocomposites due to the π–π stacking inter-
actions between THI and graphene. A total of 1.0 mL of
AuNP solution was mixed with 200.0 μL of the as-
prepared NH2-GO/THI nanocomposites and stirred for
another 12 h. The AuNP solution was presynthesized with
diameters of ~15 nm. Eventually, NH2-GO/THI/AuNP
nanocomposites were obtained through several cen-
trifugation and washing steps.
As shown in Fig. 2, 10.0 μL of synthesized NH2-GO/
THI/AuNP nanocomposites were coated on the WE
surface and dried at 50 °C in an oven. A total of 10.0 μL of
1 mM anti-EGFR aptamers were covalently immobilized
on the modified WE through Au-S bonds. Subsequently,
10.0 μL of mercaptoethanol solution, whose concentra-
tion was 1.0 mM, was used to block the nonspecific
Front Side Front Side Back Side
Screen-printing
WE
Screen-printing
CE & RE
CuttingFolding
Fig. 1 Design and fabrication process of the origami-paper-based device
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binding sites at room temperature for 1 h. Finally, TE
buffer (10.0 mM Tris-HCl and 1.0 mM EDTA) was
employed to wash the fabricated origami-paper-based
aptasensor several times. The device was stored at 4 °C.
Electrochemical measurements of EGFR
The performance of the abovementioned origami-
paper-based aptasensor was evaluated by assaying stan-
dard solutions of EGFR. 5.0 μL of biological sample (e.g.,
serum), spiked with different EGFR concentrations in the
range between 1.0 pgmL−1 and 500 ngmL−1, were intro-
duced from the sample inlet hole located at the side of the
device. The devices were stored for up to 1 h before
electrochemical measurement. A solution of 0.1M PBS
solution (pH= 7.4) was added to the sample and an
Autolab electrochemical workstation was used to perform
the electrochemical characterization. CV and DPV were
utilized for the characterization of the fabricated paper-
based aptasensor because they were accurate and highly
sensitive. The typical CV responses were recorded at a
scan rate of 100mVs−1 between −0.5 V and 0.1 V. In
addition, the DPV responses of various concentrations of
EGFR were obtained under conditions of 5.0 mV step
potential, 0.025 s modulation time, and 0.5 s interval time
in the range of −0.5 V to 0.1 V.
Results and discussion
Working principle of the origami-paper-based
electrochemical aptasensor
The origami-paper-based device was separated into
three sheets. Three electrodes were screen printed onto
different sheets. Once a sample was added from the
sample inlet, it would flow through the microchannel and
permeate to the surface of the WE to enable electro-
chemical detection. The WE in this device was designed
to be separated from the counter, and REs to reduce
sample consumption and prevent the contamination of
auxiliary electrodes during the modification process.
Compared with devices that require complex networks of
channels, the origami device fabricated in this work would
ensure a more rapid test, as the time taken for fluid to
permeate was shortened. Moreover, the exclusion of some
small channels would lead to a low sample consumption
of ~4.7 μL and an increase in sensitivity. Finally, the
device was easy to insert into the backend interfaces so
that the detection results could be directly read by the
electrochemical workstation.
Characterization of synthesized NH2-GO/THI/AuNP
NH2-GO/THI/AuNP nanocomposites were synthesized
to enhance the electrochemical properties of the screen-
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Fig. 2 Modification process of the origami-paper-based EGFR aptasensor
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printed WE. They also enabled the immobilization of
anti-EGFR aptamers by using the self-assembly interac-
tions between Au and thiol groups on the aptamer. To
characterize the synthesized nanocomposites, transmis-
sion electron microscopy (TEM) images were obtained.
As shown in Fig. 3, NH2-GO showed corrugated struc-
tures, which effectively increased the surface area of the
electrode. THI, whose molecular formula is displayed in
Fig. 2, noncovalently attached to the NH2-GO surface
because of the π–π stacking interactions between benzene
rings. A larger surface area meant that more THI mole-
cules could be loaded onto the electrode surface. As
electroactive materials, THI molecules generate currents
through redox reactions. As a result, more THI molecules
present led to a higher electrochemical response. In
addition, the TEM image also demonstrates that a large
number of AuNPs were distributed on the surface of
NH2-GO, and no significant agglomeration was observed.
The diameters of the AuNPs ranged from 10 nm to
50 nm. AuNP has unique properties due to the quantum
size effect. They have a strong affinity for electrons, thus
acting as strong electron acceptors45–47, leading to an
increase in the anodic peak current (Fig. 4). From the
image, we could conclude that the nanocomposites were
synthesized successfully.
Electrochemical properties of the EGFR aptasensor
The fabrication process of the origami-paper-based
EGFR aptasensor and its corresponding electrochemical
behavior were characterized with both CV and DPV
methods in a 0.1M PBS solution (pH= 7.4). The typical
responses of CV as a result of stepwise preparation pro-
cesses are shown in Fig. 4a. The bare WE (curve a1)
showed no oxidation or reduction behavior. In compar-
ison, a well-behaved electrochemical response was
observed under the same conditions after modification
with NH2-GO/THI/AuNP nanocomposites (curve a2),
indicating that a conformal coating of the nanocompo-
sites was formed on the WE. Two pronounced redox
peaks, which were attributed to the THI molecules, were
observed at −0.18 V and −0.31 V.
The magnitude of the electrochemical response was
lower than that of the nanocomposite-modified electrodes
when EGFR aptamers were immobilized onto the elec-
trode surface (curve a3). It appears that the presence of
insulating aptamers hindered the process of electron
transfer, resulting in a decrease in the current response.
Subsequently, when different concentrations of EGFR
antigens were added (curve a4 and curve a5), the current
intensity decreased with increasing concentrations, con-
firming the fact that once the EGFR antigen bound to the
aptamer, they would influence electron transfer from the
medium to the WE. Furthermore, more insulating
immunocomplexes would form with a higher concentra-
tion of antigens, which would, in turn, result in a lower
electrochemical current. The CV results indicated the
successful fabrication and function of the electrochemical
paper-based aptasensor.
Similar behaviors were observed when DPV was utilized
for the characterization of the aptasensor. The results
obtained from DPV studies were correlated with those
from CV carried out under similar conditions. As shown
in Fig. 4b, compared with the bare WE (curve b1), the
NH2-GO/THI/AuNP-modified WE exhibited a pro-
nounced DPV response (curve b2), with a peak current of
16.99 μA. Then, the current response dropped to 14.98 μA
upon immobilization of aptamers (curve b3). Moreover,
with the addition of different concentrations of EGFR
antigen (curve b4 and curve b5), the magnitude of
the DPV response was observed to decrease gradually.
The CV and DPV results were highly consistent with the
principle of the electrochemical method mentioned ear-
lier, which indicated that the aptasensor was modified
successfully and enabled the detection of EGFR.
Optimization of the experimental conditions for the EGFR
aptasensor
To obtain a high and stable electrochemical response,
factors that influence the electrochemical currents were
optimized. During the electrochemical measurements, the
electrochemical currents were derived from the THI
molecules. Different concentrations of THI molecules led
to different electrochemical currents. AuNP provided a
suitable microenvironment for the immobilization of anti-
EGFR aptamers and enhanced charge transfer. It was
necessary to study the effect of the number of AuNPs. In
addition, instead of antibodies, aptamers were used as the
recognition element in this work. Therefore, the incuba-
tion time would also affect the performance of the
100 nm
Fig. 3 TEM image of the synthesized NH2-GO/THI/AuNP
nanocomposites
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electrochemical aptasensor. The effects of the three
abovementioned conditions were investigated.
To choose an optimal concentration of THI molecules
for the following electrochemical detection, a series of
THI solutions were prepared with concentrations ranging
between 0.5 mgmL−1 and 5.0 mgmL−1 to study its effect
on the response. Different concentrations of THI solu-
tions were mixed with a 1.0 mgmL−1 NH2-GO solution at
a ratio of 1:1 to obtain NH2-GO/THI nanocomposites and
their responses are reported in Fig. 5a. It can be observed
from the figure that the DPV response reached a max-
imum at 2.0 mgmL−1.
The AuNP played an important role in the electro-
chemical performance of the aptasensor. Different
amounts of AuNPs were mixed with the synthesized NH2-
GO/THI nanocomposites at ratios of 1:1, 2:1, 3:1, 4:1, 5:1,
6:1, and 7:1. As shown in Fig. 5b, the peak current of the
electrochemical aptasensor increased with the AuNP
amount until the ratio of 5:1 and then began to decrease
with further increases, when their amount could screen
the charge transport to the electrode.
Incubation time is another key factor that influences
performance linked to the status of the EGFR binding.
The modified aptasensor was incubated with 1.0 ngmL−1
EGFR for 15, 30, 45, 60, 75, and 90 min. As shown in
Fig. 5c, the peak current decreased gradually with
increasing incubation time and tended to level off after
60 min. As a result, 60 min was selected as the incubation
time for the following experiments.
Analytical performance of the EGFR aptasensor
Under the optimized conditions described above, the
electrochemical responses of the origami-paper-based
aptasensor were recorded as a function of EGFR con-
centration. As shown in Fig. 6a, the electrochemical
response of the aptasensor decreased continuously with
increasing concentrations of EGFR antigen. Figure 6b
shows that this decrease is linear (on a log scale, R2=
0.989). The limit of detection (LOD) of the aptasensor can
be concluded to be <5.0 pgmL−1, which was more sensi-
tive than that of the commercial EGFR ELISA kit. The
boosted electrochemical sensitivity of the aptasensor
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could be attributed not only to the nanocomposites,
which increased the current response, but also to the key
advantageous properties of aptamers over antibodies.
Comparing the characteristics of the present study with
other platforms (Table 1) indicated an excellent linear
range and a low detection limit for the detection of EGFR,
considering the ease-of-use and low cost of the platform
with respect to the other methods mentioned.
Repeatability and selectivity of the EGFR aptasensor
The repeatability of an electrochemical device, espe-
cially for such low-cost disposable paper-based format, is
a key factor for practical applications. In this work, the
repeatability was characterized by assaying 1 ngmL−1
EGFR antigen with three different devices that were fab-
ricated in the same batch. As shown in Fig. 6c, the three
independent aptasensors showed changes in current
responses of 9.203 μA, 9.328 μA, and 9.270 μA. The
coefficient of variation of the measurements was 0.79%
(<5%), showing excellent repeatability.
Selective determination of target analytes is of significant
analytical importance in clinical chemistry. To examine
the selectivity of our aptasensor, potential interferents,
carcinoembryonic antigen, neuron-specific enolase, uric
acid, ascorbic acid, dopamine, vascular endothelial growth
factor, and follicle-stimulating hormone were mixed with
1.0 ngmL−1 EGFR at a much larger concentration of
10.0 ngmL−1 for control experiments. As shown in Fig. 6d,
no significant current change was observed. Although the
concentration of interference was ten times higher than
our detection target, the current variation was <7.42% of
that without the potentially interfering species.
Analytical results of serum samples
The practicality and analytical reliability of the paper-
based aptasensor were further investigated by assaying five
serum samples spiked with different concentrations of
EGFR antigens ranging from 0.37 ngmL−1 to 4.35 ngmL−1,
compared with measurements obtained by ELISA, which
was used as a reference method (the ELISA kit enabled a
detection range only of 0.1–8.0 ngmL−1). Table 2 shows
no significant deviation between these two methods, ran-
ging from 3.58 to 7.32%. In general, the range of EGFR in
healthy individuals is ~1.0–25.0 ngmL−1. Moreover, the
R2 = 0.989
Y = 17.86–2.97X
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cutoff concentration to differentiate between a primary
diagnostic and a diagnosis of metastasis is ~30.0 ngmL−1
(ref. 48). The detection results thus confirmed that our
proposed EGFR aptasensor enabled sufficient sensitivity
for clinical applications.
Conclusion
We have demonstrated an origami-paper-based label-
free electrochemical aptasensor for ultrasensitive detec-
tion of EGFR. The device enabled a linear analytical
response range across a wide range of concentrations and
a low LOD. In summary, the proposed aptasensor com-
bines low-cost paper-based microfluidic devices with a
highly sensitive electrochemical detection. Adopting the
concept of origami further simplified the device and
reduced the sample consumption. The introduction of
graphene-based nanocomposites onto the WE surface
efficiently accelerated the electron transfer rate and further
enhanced the detection signal. The aptamer used as the
recognition element during detection enabled highly spe-
cific detection. The method provides several key advan-
tages, including ease and low cost of production, as well as
simple chemical modification to yield improved and tai-
lored properties. The aptasensor described in this work
could be easily adapted for other clinical or environmental
applications. Moreover, many existing manufacturers have
been able to integrate powerful electro-analysis functions
into a handheld potentiostat. Once combined with these
commercially available handheld instruments, the pro-
posed paper-based aptasensor would have the potential in
early diagnosis and efficacy evaluation of cancer.
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Table 1 Comparisons of different kinds of biosensors and their analytical properties toward EGFR
No. Method Linear range LOD References
1 Impedimetric immunosensor modified with gold nanoparticles 1 pgmL−1 to 1 μg·mL−1 0.34 pgmL−1 2
2 Gold nanoparticles-modified capacitive sensor 20–1000 pgmL−1 20 pgmL−1 49
3 Antibody immobilized quartz crystal microbalance 0.01–10 μgmL−1 100 ngmL−1 50
4 Electrochemical aptamer/antibody-based sandwich immunosensor 1–40 ngmL−1 50 pgmL−1 5
5 DTSP-modified electrochemical immunosensor 0.01–100 ngmL−1 1 pgmL−1 7
6 Origami-paper-based electrochemical aptasensor 0.05–200 ngmL−1 5 pgmL−1 This work
Table 2 Assay results of spiked serum samples using the EGFR aptasensor and ELISA kit
Serum samples 1 2 3 4 5
ELISA (ngmL−1) 4.35 3.44 1.27 0.82 0.37
Proposed aptasensor (ngmL−1) 4.56 3.25 1.22 0.88 0.40
Relative deviation (%) 4.72 −5.44 −3.58 6.96 7.32
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